Institute of Immunology
Gerald Willimsky has not added Biography.
If you are Gerald Willimsky and would like to personalize this page please email our Author Liaison for assistance.
Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance.
The Journal of clinical investigation Mar, 2013 | Pubmed ID: 23454765
In vitro proteasome processing of neo-splicetopes does not predict their presentation in vivo.
eLife Apr, 2021 | Pubmed ID: 33875134
Lymphocyte access to lymphoma is impaired by high endothelial venule regression.
Cell reports Oct, 2021 | Pubmed ID: 34706240
T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas.
Clinical cancer research : an official journal of the American Association for Cancer Research Jan, 2022 | Pubmed ID: 34782365
EBAG9 controls CD8+ T cell memory formation responding to tumor challenge in mice.
JCI insight Jun, 2022 | Pubmed ID: 35482418
H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2 patients with diffuse midline glioma.
Journal for immunotherapy of cancer Oct, 2022 | Pubmed ID: 36302563
Targeting the recurrent Rac1P29S neoepitope in melanoma with heterologous high-affinity T cell receptors.
Frontiers in immunology , 2023 | Pubmed ID: 36875127
Response to: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Chheda .
Journal for immunotherapy of cancer Mar, 2023 | Pubmed ID: 36918223
Early protective effect of a ("pan") coronavirus vaccine (PanCoVac) in Roborovski dwarf hamsters after single-low dose intranasal administration.
Frontiers in immunology , 2023 | Pubmed ID: 37520530
A phase I study of MAGE-A1-targeted T1367 T-cell receptor-based cell therapy in patients with advanced multiple myeloma.
Haematologica Sep, 2024 | Pubmed ID: 39279443
Natascha Drude1,
Kai Diederich2,
Claudia U. Duerr3,
Nadine Haase4,
Christoph Harms5,6,7,8,
Frank Heppner9,10,11,
Marina Jendrach9,10,11,
Pia Kahnau2,
Marina Kolesnichenko12,
Lars Lewejohann2,13,
Claudia Kurreck1,
Anke Lohan14,
Marcus A. Mall15,16,
Dominik Müller4,
Stefan Nagel-Riedasch14,
Bastian Opitz17,
Laura Schaupp15,16,
Gilbert Schönfelder2,18,
Amelie Weber3,
Gerald Willimsky19,20,21,
Yalei Zang1,22,
Stephan P. Rosshart*,23,24,
Andreas Diefenbach*,3,
Stefan Jordan*,3
1BIH QUEST Center for Responsible Research, Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin,
2German Federal Institute for Risk Assessment (BfR), German Centre for the Protection of Laboratory Animals (Bf3R),
3Institute of Microbiology, Infectious Diseases and Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin,
4, Experimental and Clinical Research Center (ECRC) & Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft (MDC),
5Department of Experimental Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Klinik und Hochschulambulanz für Neurologie,
6Center for Stroke Research Berlin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin,
7, Einstein Center for Neuroscience,
8, German Center for Cardiovascular Research (DZHK), partner site Berlin,
9Department of Neuropathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin,
10, Cluster of Excellence, NeuroCure,
11, German Center for Neurodegenerative Diseases (DZNE) Berlin,
12Department of Hepatology and Gastroenterology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin,
13Institute of Animal Welfare, Animal Behavior and Laboratory Animal Science, Freie Universität Berlin,
14Forschungseinrichtungen für Experimentelle Medizin/FEM, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin,
15Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin,
16, German Center for Lung Research (DZL), associated partner site, Berlin,
17Department of Infectious Diseases, Respiratory Medicine and Critical Care, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin,
18Division of Toxicology, Institute of Clinical Pharmacology and Toxicology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health,
19Institute of Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin,
20, German Cancer Research Center,
21, German Cancer Consortium, partner site Berlin,
22Department of Radiology (including Pediatric Radiology), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin,
23Department of Microbiome Research, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU),
24Department of Medicine II, Faculty of Medicine, Medical Center - University of Freiburg